Frontiers in Endocrinology,
Journal Year:
2024,
Volume and Issue:
15
Published: Oct. 7, 2024
Introduction
and
objectives
Recent
studies
have
indicated
a
potential
association
of
hypertension
with
Hashimoto’s
thyroiditis
(HT)
other
autoimmune
diseases,
yet
the
impact
antihypertensive
drugs
on
HT
risk
is
not
well
understood.
Methods
We
employed
drug-target
Mendelian
randomization
approach
to
investigate
prolonged
9
classes
medications
susceptibility
in
European
Asian
populations.
Genetic
variants
close
or
within
genes
associated
drug
targets
systolic
blood
pressure
(SBP)
were
utilized
mimic
effects
medications.
focused
linked
lower
coronary
artery
disease
for
our
main
analysis.
gathered
genetic
data
SBP
from
comprehensive
genome-wide
available
groups.
For
supplementary
analysis,
we
used
expression
quantitative
trait
loci
(eQTLs)
related
target
as
proxies.
Results
Our
analysis
revealed
that
use
calcium
channel
blockers
(CCBs)
reduced
both
(OR
[95%
CI]:
0.96
[0.95
0.98]
per
1
mmHg
decrease
SBP;
p
=
3.51×10
-5
)
populations
0.28
[0.12,
0.66];
3.54×10
-3
).
Moreover,
genetically
mimicking
loop
diuretics
0.94
[0.91,
0.97];
3.57×10
thiazide
(0.98
[0.96,
0.99];
3.83×10
showed
significant
decreased
only
population.
These
outcomes
confirmed
when
eQTLs
represent
Conclusion
The
study
suggests
CCBs
could
potentially
reduce
different
Additional
research
needed
assess
feasibility
repurposing
prevention
HT.
Frontiers in Cardiovascular Medicine,
Journal Year:
2025,
Volume and Issue:
11
Published: Jan. 14, 2025
Cardiometabolic
diseases
(CMD)
are
leading
causes
of
death
and
disability
worldwide,
with
complex
pathophysiological
mechanisms
in
which
inflammation
plays
a
crucial
role.
This
review
aims
to
elucidate
the
molecular
cellular
within
inflammatory
microenvironment
atherosclerosis,
hypertension
diabetic
cardiomyopathy.
In
oxidized
low-density
lipoprotein
(ox-LDL)
pro-inflammatory
cytokines
such
as
Interleukin-6
(IL-6)
Tumor
Necrosis
Factor-alpha
(TNF-α)
activate
immune
cells
contributing
foam
cell
formation
arterial
wall
thickening.
Hypertension
involves
activation
renin-angiotensin
system
(RAS)
alongside
oxidative
stress-induced
endothelial
dysfunction
local
mediated
by
T
cells.
cardiomyopathy,
high-glucose
environment
leads
accumulation
advanced
glycation
end
products
(AGEs),
activating
Receptor
for
Advanced
Glycation
Endproducts
(RAGE)
triggering
responses
that
further
damage
cardiac
microvascular
function.
summary,
different
types
metabolic
cardiovascular
diverse;
understanding
these
deeply
will
aid
developing
more
effective
individualized
treatment
strategies.
Journal of Receptors and Signal Transduction,
Journal Year:
2025,
Volume and Issue:
unknown, P. 1 - 12
Published: Jan. 13, 2025
The
proliferative
effects
of
angiotensin
(Ang)
II
in
vascular
smooth
muscle
cells
(VSMCs)
through
its
ability
to
stimulate
extracellular
signal-regulated
kinases
1
and
2
(ERK1/2)
pathway
have
been
established.
main
goal
this
study
was
explore
whether
Ang
III
induces
ERK1/2
MAPK
VSMC
proliferation
cultured
Wistar
VSMCs.
Further,
the
actions
were
compared
those
observed
VSMCs
derived
from
spontaneously
hypertensive
rat
(SHR).
We
hypothesized
that
will
similar
as
induce
cellular
may
be
different
isolated
versus
SHR
rats.
Time
and/or
concentration-dependent
determined
using
western
blot
analysis
DNA
incorporation
assay.
results
showed
phosphorylation
mediated
by
or
concentration-
time-dependent
Moreover,
less
effective
mediating
seen
induced
AT1
receptors
activation.
synthesis
via
receptor
a
manner
significant
differences
existed
peptide's
These
indicate
stimulates
receptors.
However,
these
pathways
is
reduced
Biomedicines,
Journal Year:
2024,
Volume and Issue:
12(9), P. 2096 - 2096
Published: Sept. 13, 2024
The
triad
of
vascular
impairment,
muscle
atrophy,
and
cognitive
decline
represents
critical
age-related
conditions
that
significantly
impact
health.
Vascular
impairment
disrupts
blood
flow,
precipitating
the
mass
reduction
seen
in
sarcopenia
neuronal
function
characteristic
neurodegeneration.
Our
limited
understanding
intricate
relationships
within
this
hinders
accurate
diagnosis
effective
treatment
strategies.
This
review
analyzes
interrelated
mechanisms
contribute
to
these
conditions,
with
a
specific
focus
on
oxidative
stress,
chronic
inflammation,
impaired
nutrient
delivery.
aim
is
understand
common
pathways
involved
suggest
comprehensive
therapeutic
approaches.
dysfunctions
hinder
circulation
transportation
nutrients,
resulting
characterized
by
atrophy
weakness.
dysfunction
have
negative
physical
quality
life.
Neurodegenerative
diseases
exhibit
comparable
pathophysiological
affect
motor
functions.
Preventive
approaches
encompass
lifestyle
adjustments,
addressing
integrated
therapies
improving
muscular
well-being.
Better
links
can
refine
strategies
yield
better
patient
outcomes.
study
emphasizes
complex
interplay
between
dysfunction,
degeneration,
decline,
highlighting
necessity
for
multidisciplinary
Advances
domain
promise
improved
diagnostic
accuracy,
more
options,
enhanced
preventive
measures,
all
contributing
higher
life
elderly
population.
Journal of Ultrasound in Medicine,
Journal Year:
2025,
Volume and Issue:
unknown
Published: Jan. 21, 2025
Objectives
This
study
analyzed
carotid
artery
remodeling
characteristics
in
early
atherosclerosis
(ECAS).
Methods
The
1021
participants
were
evaluated
using
ultrasonography
and
categorized
into
three
groups:
Group
A,
391
with
increased
intima‐media
thickness
(IMT);
B,
300
atherosclerotic
plaque
only
on
the
bulb
(CB);
control
group
(330
participants).
ratios
of
diameters
CB
to
those
common
(
D
CCA
)
internal
ICA
defined
as
index1
(CI
1
2
).
Results
A
had
a
higher
,
CI
than
controls
P
<
.05).
B
smaller
Logistic
regression
showed
that
was
positive
influencing
factor
for
IMT
(OR:
3.42,
95%
CI:
1.74–6.70,
.001),
negative
independent
formation
0.11,
0.04–0.28,
.001).
Multiple
linear
vessel
side
significant
influence
β
=
0.055,
.05),
while
age,
sex,
body
mass
index,
cerebrovascular
risk
factors
no
correlation
CI.
Conclusions
IMT,
however,
formation.
changes
consistent
remodeling.
an
ECAS,
it
affected
by
side,
providing
objective
predictive
parameter
ECAS.
Journal of Vascular Diseases,
Journal Year:
2025,
Volume and Issue:
4(1), P. 10 - 10
Published: March 11, 2025
Renal
artery
stenosis
(RAS)
is
a
vascular
condition
characterized
by
narrowing
of
one
or
both
renal
arteries,
leading
to
reduced
blood
flow
the
kidneys,
activation
renin–angiotensin–aldosterone
system
(RAAS),
and
subsequent
renovascular
hypertension.
Overactivation
same
cascade
potentiates
production
angiotensin
II,
which
induces
systemic
vasoconstriction,
increases
sodium
water
retention
via
aldosterone,
activates
sympathetic
nervous
system.
Angiotensin
II
also
implicated
in
endothelial
dysfunction,
oxidative
stress,
chronic
inflammation,
thus
impairing
remodeling
arterial
stiffness,
all
serve
accelerate
cardiovascular
complications,
such
as
left
ventricular
hypertrophy,
heart
failure,
myocardial
infarction.
RAS
usually
due
at
least
90%
cases
atherosclerosis,
typically
affects
older
people
with
diabetes
smoking
risk
factors.
There
are
two
types
RAS:
unilateral
bilateral.
Bilateral
commonly
associated
flash
pulmonary
edema,
life-threatening
emergency
alveolar
space
flooding
can
occur
within
minutes.
remains
asymptomatic
until
late
stage
complications
hypertension,
ischemic
nephropathy,
kidney
disease.
FMD
tends
create
structural
abnormalities
artery,
whereas
atherosclerosis
causes
plaque
formation
dysfunction
artery.
Epidemiological
surveys
have
revealed
that
prevalence
ranges
from
4%
53%
especially
high
among
patients
disease,
CKD.
Diagnosis
based
on
clinical
suspicion
supported
imaging
studies,
including
Doppler
ultrasound,
computed
tomography
angiography,
magnetic
resonance
angiography.
Early
detection
relies
certain
laboratory
biomarkers,
identifying
high-risk
patients.
These
markers
would
include
increased
plasma
renin
activity,
elevated
aldosterone-renin
ratio,
inflammatory
markers,
C-reactive
protein
endothelin-1.
Treatment
involve
pharmacological
approaches,
RAAS
inhibitors,
beta-blockers,
statins,
interventional
treatments,
angioplasty
stenting
severe
forms
However,
Cardiovascular
Outcomes
Atherosclerotic
Lesions
(CORAL)
Trial
showed
most
likely
require
medical
therapy,
intervention
should
be
reserved
for
those
uncontrolled
progressive
recurrent
episodes
edema.
Other
emerging
therapies
drug-eluting
balloons,
bioresorbable
stents,
gene-editing
techniques,
shown
great
promise
few
studies
been
conducted,
although
further
evaluation
needed.
Despite
these
advances,
there
still
gaps
knowledge
regarding
patient
stratification,
biomarker
validation,
development
personalized
treatment
strategies.
This
article
reviews
complexities
its
impact
health.
Future
research
therefore
focus
improving
early
diagnosis,
optimizing
selection
intervention,
developing
new
slow
disease
progression
mitigate
complications.
Circulation,
Journal Year:
2025,
Volume and Issue:
unknown
Published: March 18, 2025
BACKGROUND:
Phenotypic
switching
of
vascular
smooth
muscle
cells
(VSMCs),
leading
to
neointimal
hyperplasia,
is
a
fundamental
cause
remodeling
diseases
such
as
atherosclerosis
and
hypertension.
Novel
hidden
proteins
encoded
by
circular
RNAs
play
crucial
roles
in
disease
progression,
yet
their
involvement
has
not
been
comprehensively
studied.
This
study
identifies
novel
protein
derived
from
RNA
VSMCs
demonstrates
its
potential
role
regulating
remodeling.
METHODS:
Cell
proliferation
assays
were
performed
investigate
the
effects
circSETD2(14,15
)
on
VSMC
proliferation.
Techniques
vector
construction,
immunoprecipitation–mass
spectrometry,
dual-luciferase
reporter
gene
used
confirm
that
protein,
p-414aa.
The
interaction
between
p-414aa
HuR
(human
antigen
R)
was
validated
with
techniques
coimmunoprecipitation,
mass
proximity
ligation
assay.
Through
experiments
including
sequencing
immunoprecipitation,
C-FOS
(C-Fos
proto-oncogene)
mRNA
revealed.
hyperplasia
assessed
carotid
artery
model
male
mice.
RESULTS:
Overexpression
inhibits
phenotypic
switching.
p-414aa,
),
interacts
reduce
stability,
thereby
suppressing
ultimately
inhibiting
CONCLUSIONS:
We
uncover
called
CircSETD2(14,15
may
serve
therapeutic
targets
for
diseases.